Abstract: The present invention relates to a composition comprising one or more isolated probiotic bacterial strains, two or more active of the one or more isolated probiotic bacterial strains, or the combination of one or more isolated probiotic bacterial strains and two or more active of the one or more isolated probiotic bacterial strains; and an acceptable carrier, wherein the one or more isolated probiotic bacterial strains and/or the two or more active of the one or more isolated probiotic bacterial strains is capable of inhibiting fungal proliferation.

Abstract: The present invention relates to a composition comprising Lactobacillus crispatus LB714R, deposited under the accession number DSM 33732, Lactobacillus gasseri LB905R deposited under accession number DSM 34094, Lactobacillus crispatus LB912R deposited under accession number DSM 34095, Lactobacillus jensenii LB918R deposited under accession number DSM 34096, or Lactobacillus crispatus LB919R deposited under accession number DSM 34097.

Abstract: The present invention relates to a composition comprising Pediococcus pentosaceus LB606R, deposited under the assession number DSM 33730; Lactiplantibacillus plantarum, LB679R, deposited under the assession number DSM 33731; or a combination hereof.

Abstract: The present invention relates to a composition for improvement of a skin condition comprising a supernatant produced from fermentation of a bacteria wherein the supernatant comprises at least 3 metabolites produced by the bacteria during fermentation wherein the at least 3 metabolites include at least one of succinic acid, 2-Hydroxyisocaproic acid, azelaic acid and/or salicylic acid, 5 and wherein at least one of succinic acid, 2-Hydroxyisocaproic acid, azelaic acid, and/or salicylic acid is/are produced by fermentation of a lactic acid bacteria.

Abstract: A composition comprises one or more of bacterial strains wherein the one or more of bacterial strains exhibit a stronger inhibition of pathogenic C. acnes strains compared to non-pathogenic C. acnes strains.

Abstract: The present invention relates to a microcapsule comprising a fat-based coating surrounding a composition providing an encapsulated composition, the encapsulated composition comprising a viable microorganism, and a water content below 5% (w/w).